AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10102976 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg
Number of subjects: 609
Study 10102976 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 10 mg
Number of subjects: 609
Study 7555986 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin (VGB) at 40 mg/kg/day, increased to 60 and 80 mg/kg/day if seizures persisted
Number of subjects: 46
Study 7555986 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin (VGB)
Number of subjects: 46
Study 7555986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 1983701 — intervention group
Group type: EXPERIMENTAL
Intervention: Five anxiolytic benzodiazepines taken nocte for 7 days
Number of subjects: 28
Study 7028299 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminium phosphate-adsorbed cholera vaccine
Number of subjects: 0
Study 7028299 — intervention group
Group type: COMPARATOR
Intervention: Aluminium phosphate-adsorbed tetanus toxoid (placebo)
Number of subjects: 0
Study 31462185 — intervention group
Group type: EXPERIMENTAL
Intervention: Zika virus (ZIKV) IgM
Number of subjects: 100
Study 31462185 — intervention group
Group type: EXPERIMENTAL
Intervention: Zika virus (ZIKV) IgG
Number of subjects: 100
Study 31462185 — intervention group
Group type: EXPERIMENTAL
Intervention: Zika virus (ZIKV) IgM or IgG or both
Number of subjects: 100
Study 31462185 — intervention group
Group type: EXPERIMENTAL
Intervention: Malaria
Number of subjects: 100
Study 31462185 — intervention group
Group type: EXPERIMENTAL
Intervention: Malaria and ZIKV IgM, IgG or both
Number of subjects: 100
Study 31290176 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-G fine-needle biopsy (FNB)
Number of subjects: 125
Study 28669488 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge Hyponatremia (Na <135 meq/L)
Number of subjects: 306
Study 28669488 — intervention group
Group type: COMPARATOR
Intervention: Normal Sodium on Discharge
Number of subjects: 306
Study 25368103 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified radical hysterectomy
Number of subjects: 240
Study 23818295 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol based therapy (antibiotic regimens for eradication of newly identified Pseudomonas)
Number of subjects: 304
Study 23818295 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (historical controls from 1995 to 1998)
Number of subjects: 304
Study 23818295 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol based therapy
Number of subjects: 304
Study 23818295 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 304
Study 21256809 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b (10 million units flat dose subcutaneously 5 days per week for 4 weeks, then 10 million units flat dose subcutaneously 3 days per week for 12 months) - Group B
Number of subjects: 855
Study 21256809 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b (10 million units flat dose subcutaneously 5 days per week for 1 month, then 10 million units flat dose subcutaneously 3 days per week for 24 months) - Group C
Number of subjects: 855
Study 21256809 — intervention group
Group type: COMPARATOR
Intervention: Observation only - Group A
Number of subjects: 855
Study 19486349 — intervention group
Group type: EXPERIMENTAL
Intervention: Current drinkers
Number of subjects: 32347
Study 19486349 — intervention group
Group type: EXPERIMENTAL
Intervention: Past drinkers
Number of subjects: 32347
Study 19486349 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol intake frequency and duration
Number of subjects: 32347
Study 17057382 — intervention group
Group type: EXPERIMENTAL
Intervention: levodopa
Number of subjects: 0
Study 17057382 — intervention group
Group type: COMPARATOR
Intervention: placebo pill
Number of subjects: 0
Study 17057382 — intervention group
Group type: COMPARATOR
Intervention: sham TMS
Number of subjects: 0
Study 14691389 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.4 g/kg every 4 hr in 200 ml of orange juice)
Number of subjects: 50
Study 14691389 — intervention group
Group type: COMPARATOR
Intervention: Orange juice without ethanol
Number of subjects: 50
Study 11154618 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg Ginkgo biloba extract LI 1370 three times daily for 12 weeks
Number of subjects: 1121
Study 11154618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1121
Study 9884858 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil 1 microgram kg‐1
Number of subjects: 60
Study 9884858 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil 1 microgram kg‐1 and lignocaine 1 mg kg‐1
Number of subjects: 60
Study 9884858 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil 2 micrograms kg‐1
Number of subjects: 60
Study 7926537 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous endoscopic gastrostomy (PEG) procedure
Number of subjects: 68
Study 2744770 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocked highlighting
Number of subjects: 0
Study 2744770 — intervention group
Group type: EXPERIMENTAL
Intervention: Random highlighting
Number of subjects: 0
Study 2744770 — intervention group
Group type: COMPARATOR
Intervention: No highlighting
Number of subjects: 0
Study 1111453 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous clindamycin phosphate
Number of subjects: 0
Study 1111453 — intervention group
Group type: COMPARATOR
Intervention: Methicillin
Number of subjects: 0
Study 7031847 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg trimipramine at night
Number of subjects: 45
Study 7031847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 30608175 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck Balance System (NBS)
Number of subjects: 20
Study 30608175 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck Balance System (NBS) + Lumbar Support (LS)
Number of subjects: 20
Study 30608175 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar Support (LS)
Number of subjects: 20
Study 30608175 — intervention group
Group type: COMPARATOR
Intervention: No Devices (ND)
Number of subjects: 20
Study 29729518 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 122
Study 29729518 — intervention group
Group type: EXPERIMENTAL
Intervention: Black Carbon (BC)
Number of subjects: 122
Study 29729518 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction of PA and BC
Number of subjects: 122
Study 29729518 — intervention group
Group type: COMPARATOR
Intervention: Physical Activity (PA) and Black Carbon (BC)
Number of subjects: 122
Study 26321238 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT‐On
Number of subjects: 614
Study 26321238 — intervention group
Group type: COMPARATOR
Intervention: CRT‐Off
Number of subjects: 614
Study 25533977 — intervention group
Group type: EXPERIMENTAL
Intervention: Cage implantation in intervertebral space (Group A)
Number of subjects: 87
Study 25533977 — intervention group
Group type: COMPARATOR
Intervention: Autogenous morselized bone (Group B)
Number of subjects: 87
Study 25533977 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 87
Study 25533977 — intervention group
Group type: EXPERIMENTAL
Intervention: Cage implantation (Group A)
Number of subjects: 87
Study 22265034 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-emptive ibuprofen (400 mg)
Number of subjects: 61
Study 22265034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 19938164 — intervention group
Group type: EXPERIMENTAL
Intervention: PD SAFEx (exercise program with increased attention to sensory feedback)
Number of subjects: 0
Study 19938164 — intervention group
Group type: COMPARATOR
Intervention: non‐SAFE control group (exercise program without increased attention to sensory feedback)
Number of subjects: 0
Study 19938164 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PD SAFEx and non‐SAFE)
Number of subjects: 0
Study 17983800 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir 0.5 mg
Number of subjects: 709
Study 17983800 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine 100 mg
Number of subjects: 709
Study 15837968 — intervention group
Group type: COMPARATOR
Intervention: ABVD chemotherapy (doxorubicin, bleomycin, vinblastine, and dacarbazine)
Number of subjects: 399
Study 15837968 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy (subtotal nodal radiation for favorable risk or combined-modality therapy for unfavorable risk)
Number of subjects: 399
Study 15837968 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined-modality treatment (for unfavorable risk patients)
Number of subjects: 399
Study 12495553 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba capsules (120 mg)
Number of subjects: 0
Study 12495553 — intervention group
Group type: COMPARATOR
Intervention: Ginkgold (reference product)
Number of subjects: 0
Study 9872352 — intervention group
Group type: EXPERIMENTAL
Intervention: Benfotiamine
Number of subjects: 84
Study 9872352 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of benfotiamine and vitamins B6 and B12
Number of subjects: 84
Study 9872352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 7759675 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally sensitive interventions based on a framework of eight dimensions (language, persons, metaphors, content, concepts, goals, methods, and context)
Number of subjects: 0
Study 7759675 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally sensitive perspective to treatment outcome research
Number of subjects: 0
Study 2240721 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic Activitrax pacemakers with intra- and inter-flight threshold re-programming and external magnet application
Number of subjects: 4
Study 380718 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglycolic acid 3/0
Number of subjects: 48
Study 380718 — intervention group
Group type: COMPARATOR
Intervention: Chromic catgut 3/0
Number of subjects: 48
Study 31833168 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT-guided strategy (n = 370)
Number of subjects: 742
Study 31833168 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n = 372)
Number of subjects: 742
Study 31833168 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 742
Study 29785857 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Structured Criterion (VSC)
Number of subjects: 0
Study 29785857 — intervention group
Group type: EXPERIMENTAL
Intervention: ALIV (Actual and Linearly Interpolated Values)
Number of subjects: 0
Study 29785857 — intervention group
Group type: COMPARATOR
Intervention: Binomial test
Number of subjects: 0
Study 28747453 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum MMP-9 levels
Number of subjects: 3186
Study 24698216 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 74
Study 24698216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 23941739 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive servoventilation (ASV)
Number of subjects: 51
Study 23941739 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study 21040937 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet
Number of subjects: 6
Study 21040937 — intervention group
Group type: COMPARATOR
Intervention: Well-balanced diet
Number of subjects: 6
Study 19253122 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg desloratadine
Number of subjects: 0
Study 19253122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18046976 — intervention group
Group type: EXPERIMENTAL
Intervention: zofenopril 30-60 mg once daily
Number of subjects: 304
Study 18046976 — intervention group
Group type: COMPARATOR
Intervention: atenolol 50-100 mg once daily
Number of subjects: 304
Study 18046976 — intervention group
Group type: EXPERIMENTAL
Intervention: zofenopril
Number of subjects: 304
Study 18046976 — intervention group
Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 304
Study 15037401 — intervention group
Group type: EXPERIMENTAL
Intervention: Single blastocyst transfer
Number of subjects: 48
Study 15037401 — intervention group
Group type: COMPARATOR
Intervention: Two blastocysts transfer
Number of subjects: 48
Study 11400817 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microg recombinant vaccine intramuscularly (IM)
Number of subjects: 165
Study 11400817 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 microg recombinant vaccine intradermally (ID)
Number of subjects: 165
Study 9171806 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated treatment
Number of subjects: 217
Study 9171806 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 217
Study 8350215 — intervention group
Group type: COMPARATOR
Intervention: High-dose steroids
Number of subjects: 24
Study 8350215 — intervention group
Group type: EXPERIMENTAL
Intervention: Elemental diet
Number of subjects: 24
Study 8350215 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose steroids and Elemental diet
Number of subjects: 24
Study 3538789 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 70
Study 3538789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 28704308 — intervention group
Group type: EXPERIMENTAL
Intervention: Tournament Games (TG)
Number of subjects: 10
Study 28704308 — intervention group
Group type: COMPARATOR
Intervention: League Games (LG)
Number of subjects: 10
Study 27711915 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary Furlow palatoplasty
Number of subjects: 20
Study 27711915 — intervention group
Group type: COMPARATOR
Intervention: Secondary Furlow palatoplasty
Number of subjects: 20
Study 26676737 — intervention group
Group type: EXPERIMENTAL
Intervention: One-year vocational retraining program
Number of subjects: 1028
Study 26676737 — intervention group
Group type: COMPARATOR
Intervention: Two-year vocational retraining program
Number of subjects: 1028
Study 22382923 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction on ICMJE authorship criteria
Number of subjects: 203
Study 22382923 — intervention group
Group type: COMPARATOR
Intervention: No instruction on ICMJE authorship criteria
Number of subjects: 203
Study 21665534 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (active comparator)
Number of subjects: 10
Study 21665534 — intervention group
Group type: COMPARATOR
Intervention: tRNS
Number of subjects: 10
Study 21665534 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 10
Study 18437071 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care interventions
Number of subjects: 21
Study 16530757 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (viagra) 100 mg
Number of subjects: 14
Study 16530757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 14530679 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligasure
Number of subjects: 34
Study 14530679 — intervention group
Group type: COMPARATOR
Intervention: Conventional diathermy
Number of subjects: 34
Study 10764172 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal 0.5 mg morphine (Group IT0.5)
Number of subjects: 40
Study 10764172 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal 0.1 mg morphine (Group IT0.1)
Number of subjects: 40
Study 10764172 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous 10 mg morphine (Group IV)
Number of subjects: 40
Study 10764172 — intervention group
Group type: COMPARATOR
Intervention: Inhalation anesthesia alone (Group C)
Number of subjects: 40
Study 8844444 — intervention group
Group type: EXPERIMENTAL
Intervention: VX-366 (1, 7, 14 or 28 grams or approximately 14, 100, 200 or 400 mg/kg)
Number of subjects: 24
Study 8844444 — intervention group
Group type: EXPERIMENTAL
Intervention: VX-366 (100 to 150 mg/kg)
Number of subjects: 24
Study 8844444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 1393470 — intervention group
Group type: EXPERIMENTAL
Intervention: Bag method
Number of subjects: 20
Study 1393470 — intervention group
Group type: COMPARATOR
Intervention: Rack method
Number of subjects: 20
Study 6190318 — intervention group
Group type: EXPERIMENTAL
Intervention: simultaneous radio-chemotherapy
Number of subjects: 55
Study 6190318 — intervention group
Group type: EXPERIMENTAL
Intervention: early second-look operation
Number of subjects: 55
Study 31358145 — intervention group
Group type: EXPERIMENTAL
Intervention: mSCUBA technique
Number of subjects: 20
Study 31358145 — intervention group
Group type: COMPARATOR
Intervention: Peripheral blunt dissection technique
Number of subjects: 20
Study 28320978 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory workplace improvement (PWI) based ergonomic training sessions provided to on-site managers (3 sessions with 1-month intervals) and ergonomic action checklists (ACLs).
Number of subjects: 0
Study 28320978 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study 25300916 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality-based buffet restaurant intervention
Number of subjects: 221
Study 25300916 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of calories chosen for girls' meals
Number of subjects: 221
Study 25300916 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of calories chosen for boys' meals
Number of subjects: 221
Study 23558909 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (GDT) with continuous monitoring of stroke volume variation (SVV) and stroke volume (SV) using FloTrac/Vigileo, receiving 1,589 ml of colloids during surgery.
Number of subjects: 64
Study 23558909 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (GDT) with continuous monitoring of stroke volume variation (SVV) and stroke volume (SV) using FloTrac/Vigileo, SVV decreased from 9.0 to 8.0 % during surgery.
Number of subjects: 64
Study 23558909 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) receiving 927 ml of colloids during surgery.
Number of subjects: 64
Study 23558909 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (GDT)
Number of subjects: 64
Study 22011394 — intervention group
Group type: EXPERIMENTAL
Intervention: e-referral system for smoking cessation
Number of subjects: 2
Study 19793161 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent cognitive behavioral group intervention (8 weekly sessions + 1 booster session)
Number of subjects: 540
Study 16393262 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold dry air (CDA)
Number of subjects: 41
Study 14700554 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) replacement for 12 months
Number of subjects: 24
Study 14700554 — intervention group
Group type: COMPARATOR
Intervention: Baseline evaluation
Number of subjects: 24
Study 11504771 — intervention group
Group type: EXPERIMENTAL
Intervention: N-(4-hydroxyphenyl)retinamide (4-HPR)
Number of subjects: 57
Study 11504771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 8500244 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine plus isosorbide dinitrate
Number of subjects: 0
Study 8500244 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 0
Study 8500244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2964253 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (2.5-10 mg daily, titrated at 2 weekly intervals for 8 weeks)
Number of subjects: 30
Study 2964253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 2964253 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg daily)
Number of subjects: 30
Study 2964253 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (various doses)
Number of subjects: 30
Study 30608742 — intervention group
Group type: EXPERIMENTAL
Intervention: Magic-Intensity Optical Dipole Trap (MI-ODT) array
Number of subjects: 16
Study 30608742 — intervention group
Group type: EXPERIMENTAL
Intervention: Single MI-ODT
Number of subjects: 16
Study 27370308 — intervention group
Group type: EXPERIMENTAL
Intervention: STARR with curved alone stapler (CAS group)
Number of subjects: 254
Study 27370308 — intervention group
Group type: COMPARATOR
Intervention: STARR with combined use of linear and curved staplers (LCS group)
Number of subjects: 254
Study 27370308 — intervention group
Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 254
Study 25907985 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Intervention (LSI)
Number of subjects: 601
Study 25907985 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 601
Study 23975134 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicines for nourishing yin, supplementing qi, and activating blood combined with hydroxychloroquine sulfate tablets
Number of subjects: 66
Study 23975134 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine sulfate tablets
Number of subjects: 66
Study 20500279 — intervention group
Group type: EXPERIMENTAL
Intervention: One-month hospital-based clinic intervention
Number of subjects: 157
Study 20500279 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 157
Study 18955424 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinaesthetic ability training device in addition to a conventional rehabilitation programme for four weeks, five days a week
Number of subjects: 30
Study 18955424 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation programme
Number of subjects: 30
Study 18955424 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinaesthetic ability training device
Number of subjects: 30
Study 16651294 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC)
Number of subjects: 28
Study 16651294 — intervention group
Group type: COMPARATOR
Intervention: Incubator care
Number of subjects: 28
Study 12535040 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion anaesthesia (3 mg x kg‐1 induction, 20, 15 and 10 mg x kg‐1 x h‐1 maintenance)
Number of subjects: 36
Study 12535040 — intervention group
Group type: COMPARATOR
Intervention: Thiopenthal induction (5 mg x kg‐1) followed by halothane maintenance (2-3%)
Number of subjects: 36
Study 10377733 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN) therapy for chronic HBV hepatitis: 5 MU thrice weekly for 6 months
Number of subjects: 1122